Global Multiplex Biomarker Imaging Industry to attain a worth of US$ 1,041.7 Million by 2029 | FMI

According to a recent industry report by Future Market Insights (FMI), the global multiplex biomarker imaging industry is projected to reach US$ 1,041.7 million by 2029, from an estimated US$ 475.2 million in 2022. Over the course of the forecast period, the global multiplex biomarker imaging market is expected to grow significantly due to the …

Global Dermal Fillers and Botulinum Toxin Industry value is expected to experience a noteworthy surge, potentially hitting US$ 10.5 Billion by 2032

The 2022, the global dermal fillers and botulinum toxin industry demand to be valued at US$ 5.9 billion. From 2022 to 2032, the market is projected to grow at a compound annual growth rate of 6.1%. By the end of 2032, the market is expected to be valued at approximately US$ 10.5 billion. With a …

Global Diabetic Macular Edema Industry is predicted to achieve a US$ 4.2 Billion valuation by 2032

By the end of 2022, the global diabetic macular edema industry size is predicted to be valued US$ 3.7 billion. From 2022 to 2032, it is projected to grow at a compound annual growth rate (CAGR) of 1.2%. By the end of 2032, the market is expected to be valued at approximately US$ 4.2 billion. …

Global Farm Animal Drugs Industry is poised for a 5.5% CAGR by 2032 upsurge, fueled by escalating interest in solutions for animal well-being:  FMI

By the end of 2022, the global farm animal pharmaceutical industry size is projected to grow to a value of US$ 17.2 billion. The market is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2022 to 2032, when it is valued at US$ 29.4 billion. Livestock animals will account for …

Global Protein A Resins Industry to surge to US$ 1,477.01 Million by 2033, propelled by the rush for Monoclonal Antibodies | Future Market Insights

The global protein a resins industry size is projected to reach US$ 677.84 million in 2023. According to a recent analysis by Future Market Insights, the market would likely reach US$ 1,477.01 million by 2033. From 2023 to 2033, the market is projected to grow at a CAGR of 8.1%. Protein A resins are used …

Traditional Wound Management Industry Attains a Valuation of US$ 6.9 Billion in 2032-FMI Report

In 2022, the traditional wound management industry  was estimated to be worth US$5,059.1 million. In 2023, the market will be valued US$5,185.6 million. From 2023 to 2033, the global market for wound assessment and treatment is expected to grow at a compound annual growth rate (CAGR) of 2.5%. By 2033, the total market valuation is …

Global Specialty Active Pharmaceutical Ingredients Industry is on track to achieve a US$ 282.88 Billion valuation by 2033, growing at a 3.2% CAGR: as forecasted by FMI

The global specialty active pharmaceutical ingredient industry size was valued at US$ 196.8 billion in 2022. The overall market is anticipated to increase at a CAGR of 3.2% through 2033. This market analysis further predicts the market value to reach up to US$ 282.88 billion by 2033 from US$ 206.44 billion in 2023. Contract AI …

Excimer and Femtosecond Ophthalmic Lasers Industry Surges Beyond US$ 2.41 Billion by 2032-FMI Report

By the end of 2022, the global excimer and femtosecond ophthalmic lasers industry is predicted to be valued at US$ 1.18 billion, up from US$ 1.02 billion in 2021. Additionally, the global prevalence of eye diseases and the growing uptake of ophthalmic lasers are expected to drive an 8.0% compound annual growth rate (CAGR) in …

Global Silent Scan Technology Industry is expected to reaching US$ 907.9 Million by 2033, with a 2.6% CAGR | FMI

The global silent scan technology industry size valuation is US$ 702.4 million in 2023 and is expected to reach US$ 907.9 million by 2033. The global market registers a CAGR of 2.6% during the forecast period. Trends and Opportunities in the Silent Scan Technology Market: Artificial Intelligence Integration: The increasing demand for high-quality visualization and improved accuracy …

Liquid Biopsy Industry Set to Surge Beyond US$ 4,126 Million by 2032-FMI Report

It is projected that the global liquid biopsy industry would generate US$ 1,538.3 million in revenue by 2023. According to our healthcare domain specialists, liquid biopsy providers should anticipate strong growth, with a projected revenue of US$ 10,938.6 million by 2033 and a CAGR of 21.7% through that year. One of the key factors driving …